array:19 [
  "pii" => "X021169950002582X"
  "issn" => "02116995"
  "estado" => "S300"
  "fechaPublicacion" => "2000-02-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2000;20 Supl 1:20"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 1532
    "formatos" => array:3 [
      "EPUB" => 168
      "HTML" => 1123
      "PDF" => 241
    ]
  ]
  "itemSiguiente" => array:15 [
    "pii" => "X0211699500025811"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2000-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2000;20 Supl 1:21"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1670
      "formatos" => array:3 [
        "EPUB" => 161
        "HTML" => 1253
        "PDF" => 256
      ]
    ]
    "es" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Déficit en la excrección de sobrecarga de sal, resistencia a la insulina y disfunción endotelial en la hipertensión"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "21"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "C. FERNÁNDEZ-ANDRADE"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "C. FERNÁNDEZ-ANDRADE"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025811?idApp=UINPBA000064"
    "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025811/v0_201502091333/es/main.assets"
  ]
  "itemAnterior" => array:15 [
    "pii" => "X0211699500025838"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2000-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2000;20 Supl 1:19"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 3500
      "formatos" => array:3 [
        "EPUB" => 168
        "HTML" => 2829
        "PDF" => 503
      ]
    ]
    "es" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "«EL RIÑÓN EN LA HIPERTENSIÓN ESENCIAL» Papel del riñón en la patogénesis de la hipertensión arterial"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "19"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "L. M. RUILOPE"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "L. M. RUILOPE"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025838?idApp=UINPBA000064"
    "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025838/v0_201502091333/es/main.assets"
  ]
  "en" => array:8 [
    "idiomaDefecto" => true
    "titulo" => "Renal dopaminergic mechanisms and hypertension"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "20"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "J. SANTOS , M. PESTANA , A. FERREIRA , P. SAARES-DA-SILVA"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "J. SANTOS , M. PESTANA , A. FERREIRA , P. SAARES-DA-SILVA"
          ]
        ]
      ]
    ]
    "textoCompleto" => "NEFROLOGÍA. Vol. XX. Suplemento 1. 2000 Renal dopaminergic mechanisms and hypertension M. Pestana, A. Ferreira, J. Santos and P. Soares-da-Silva Department of Nephrology and Institute of Pharmacology and Therapeutics, Faculty of Medicine, 4200, Porto, Portugal. Several studies have shown that the kidney has both prohypertensive and antihypertensive functions. Because dopamine (DA) which is synthesised in renal proximal tubules from filtered L-3,4-dihydroxyphenylalanine (L-DOPA) is both vasodilatory and natriuretic, it plays an important paracrine/autocrine role in the regulation of renal function. The relative importance of this system in controlling natriuresis assumes particular relevance in view of the findings that salt sensitive (SS) hypertensives (HT) may have a fault in renal dopamine production and this may be associated with salt sensitivity of their blood pressure (BP). In the renal proximal tubules, dopamine may be metabolised by intracellular monoamine oxidase (MAO) to dihydroxyphenylacetic acid (DOPAC), before having access to the urine. Thus, the functional activity of dopamine released by the epithelial cells might depend in part on the MAO activity. The recovery of renal function in renal transplant recipients is accompanied by an enhanced ability to synthesise dopamine and deaminate it to DOPAC, which may contribute to maintain sodium homeostasis. Patients suffering from chronic renal parenchymal disease, a well recognised form of SS hypertension, have a reduced ability to produce dopamine and deaminate it to DOPAC, which correlates well with deterioration of renal function. In patients with IgA nephropathy, but normal renal function, urinary excretion of dopamine correlates positively with BP responses to changes from 20 to 350 mmol/day sodium intake. Patients afflicted with minimal change nephrotic syndrome and heart failure present with an increase in DA/L-DOPA urinary ratios. This suggests that these edema formation conditions are accompanied with an increased ability to take up or decarboxylate L-DOPA in renal tubules. It is concluded that activity of renal dopaminergic system is altered in subjects with renal parenchymal diseases and this may contribute to salt sensitibity of their BP. An enhanced delivery of L-DOPA to the kidney may be beneficial in edema formation states. The urinary levels of DOPAC may represent a good marker of renal production of dopamine as well as a good index of cell integrity and viability. Supported by Grant 84/99 from CFICS. 20 "
    "pdfFichero" => "P7-E170-S140-A1872.pdf"
    "tienePdf" => true
  ]
  "idiomaDefecto" => "en"
  "url" => "/02116995/00000020000000S1/v0_201502091333/X021169950002582X/v0_201502091333/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35407"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Suplementos"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/00000020000000S1/v0_201502091333/X021169950002582X/v0_201502091333/en/P7-E170-S140-A1872.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X021169950002582X?idApp=UINPBA000064"
]
Compartir
Información de la revista

Estadísticas

Siga este enlace para acceder al texto completo del artículo

Renal dopaminergic mechanisms and hypertension
J. SANTOS , M. PESTANA , A. FERREIRA , P. SAARES-DA-SILVA
Leído
3915
Veces
se ha leído el artículo
1489
Total PDF
2426
Total HTML
Compartir estadísticas
 array:19 [
  "pii" => "X021169950002582X"
  "issn" => "02116995"
  "estado" => "S300"
  "fechaPublicacion" => "2000-02-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2000;20 Supl 1:20"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 1532
    "formatos" => array:3 [
      "EPUB" => 168
      "HTML" => 1123
      "PDF" => 241
    ]
  ]
  "itemSiguiente" => array:15 [
    "pii" => "X0211699500025811"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2000-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2000;20 Supl 1:21"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1670
      "formatos" => array:3 [
        "EPUB" => 161
        "HTML" => 1253
        "PDF" => 256
      ]
    ]
    "es" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Déficit en la excrección de sobrecarga de sal, resistencia a la insulina y disfunción endotelial en la hipertensión"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "21"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "C. FERNÁNDEZ-ANDRADE"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "C. FERNÁNDEZ-ANDRADE"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025811?idApp=UINPBA000064"
    "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025811/v0_201502091333/es/main.assets"
  ]
  "itemAnterior" => array:15 [
    "pii" => "X0211699500025838"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2000-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2000;20 Supl 1:19"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 3500
      "formatos" => array:3 [
        "EPUB" => 168
        "HTML" => 2829
        "PDF" => 503
      ]
    ]
    "es" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "«EL RIÑÓN EN LA HIPERTENSIÓN ESENCIAL» Papel del riñón en la patogénesis de la hipertensión arterial"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "19"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "L. M. RUILOPE"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "L. M. RUILOPE"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025838?idApp=UINPBA000064"
    "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025838/v0_201502091333/es/main.assets"
  ]
  "en" => array:8 [
    "idiomaDefecto" => true
    "titulo" => "Renal dopaminergic mechanisms and hypertension"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "20"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "J. SANTOS , M. PESTANA , A. FERREIRA , P. SAARES-DA-SILVA"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "J. SANTOS , M. PESTANA , A. FERREIRA , P. SAARES-DA-SILVA"
          ]
        ]
      ]
    ]
    "textoCompleto" => "NEFROLOGÍA. Vol. XX. Suplemento 1. 2000 Renal dopaminergic mechanisms and hypertension M. Pestana, A. Ferreira, J. Santos and P. Soares-da-Silva Department of Nephrology and Institute of Pharmacology and Therapeutics, Faculty of Medicine, 4200, Porto, Portugal. Several studies have shown that the kidney has both prohypertensive and antihypertensive functions. Because dopamine (DA) which is synthesised in renal proximal tubules from filtered L-3,4-dihydroxyphenylalanine (L-DOPA) is both vasodilatory and natriuretic, it plays an important paracrine/autocrine role in the regulation of renal function. The relative importance of this system in controlling natriuresis assumes particular relevance in view of the findings that salt sensitive (SS) hypertensives (HT) may have a fault in renal dopamine production and this may be associated with salt sensitivity of their blood pressure (BP). In the renal proximal tubules, dopamine may be metabolised by intracellular monoamine oxidase (MAO) to dihydroxyphenylacetic acid (DOPAC), before having access to the urine. Thus, the functional activity of dopamine released by the epithelial cells might depend in part on the MAO activity. The recovery of renal function in renal transplant recipients is accompanied by an enhanced ability to synthesise dopamine and deaminate it to DOPAC, which may contribute to maintain sodium homeostasis. Patients suffering from chronic renal parenchymal disease, a well recognised form of SS hypertension, have a reduced ability to produce dopamine and deaminate it to DOPAC, which correlates well with deterioration of renal function. In patients with IgA nephropathy, but normal renal function, urinary excretion of dopamine correlates positively with BP responses to changes from 20 to 350 mmol/day sodium intake. Patients afflicted with minimal change nephrotic syndrome and heart failure present with an increase in DA/L-DOPA urinary ratios. This suggests that these edema formation conditions are accompanied with an increased ability to take up or decarboxylate L-DOPA in renal tubules. It is concluded that activity of renal dopaminergic system is altered in subjects with renal parenchymal diseases and this may contribute to salt sensitibity of their BP. An enhanced delivery of L-DOPA to the kidney may be beneficial in edema formation states. The urinary levels of DOPAC may represent a good marker of renal production of dopamine as well as a good index of cell integrity and viability. Supported by Grant 84/99 from CFICS. 20 "
    "pdfFichero" => "P7-E170-S140-A1872.pdf"
    "tienePdf" => true
  ]
  "idiomaDefecto" => "en"
  "url" => "/02116995/00000020000000S1/v0_201502091333/X021169950002582X/v0_201502091333/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35407"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Suplementos"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/00000020000000S1/v0_201502091333/X021169950002582X/v0_201502091333/en/P7-E170-S140-A1872.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X021169950002582X?idApp=UINPBA000064"
]
Información del artículo
ISSN: 02116995
Idioma original: Inglés
Datos actualizados diariamente
año/Mes Html Pdf Total
2024 Noviembre 7 10 17
2024 Octubre 42 34 76
2024 Septiembre 35 24 59
2024 Agosto 43 53 96
2024 Julio 33 29 62
2024 Junio 41 27 68
2024 Mayo 54 41 95
2024 Abril 32 20 52
2024 Marzo 35 19 54
2024 Febrero 34 33 67
2024 Enero 18 18 36
2023 Diciembre 19 21 40
2023 Noviembre 21 25 46
2023 Octubre 25 22 47
2023 Septiembre 23 22 45
2023 Agosto 24 22 46
2023 Julio 24 26 50
2023 Junio 30 20 50
2023 Mayo 27 24 51
2023 Abril 10 19 29
2023 Marzo 15 15 30
2023 Febrero 24 15 39
2023 Enero 22 19 41
2022 Diciembre 26 23 49
2022 Noviembre 26 26 52
2022 Octubre 34 36 70
2022 Septiembre 29 33 62
2022 Agosto 24 20 44
2022 Julio 26 39 65
2022 Junio 23 19 42
2022 Mayo 19 22 41
2022 Abril 31 25 56
2022 Marzo 27 41 68
2022 Febrero 24 23 47
2022 Enero 20 30 50
2021 Diciembre 12 27 39
2021 Noviembre 16 26 42
2021 Octubre 28 36 64
2021 Septiembre 14 24 38
2021 Agosto 17 29 46
2021 Julio 17 29 46
2021 Junio 11 12 23
2021 Mayo 19 24 43
2021 Abril 15 33 48
2021 Marzo 25 16 41
2021 Febrero 17 6 23
2021 Enero 8 11 19
2020 Diciembre 25 7 32
2020 Noviembre 11 4 15
2020 Octubre 14 4 18
2020 Septiembre 6 10 16
2020 Agosto 14 5 19
2020 Julio 18 5 23
2020 Junio 14 11 25
2020 Mayo 20 10 30
2020 Abril 16 9 25
2020 Marzo 7 7 14
2020 Febrero 29 11 40
2020 Enero 30 13 43
2019 Diciembre 15 9 24
2019 Noviembre 15 2 17
2019 Octubre 6 1 7
2019 Septiembre 10 10 20
2019 Agosto 12 6 18
2019 Julio 11 10 21
2019 Junio 8 4 12
2019 Mayo 5 6 11
2019 Abril 20 23 43
2019 Marzo 9 6 15
2019 Febrero 6 11 17
2019 Enero 5 5 10
2018 Diciembre 18 19 37
2018 Noviembre 19 6 25
2018 Octubre 22 8 30
2018 Septiembre 23 10 33
2018 Agosto 15 7 22
2018 Julio 12 4 16
2018 Junio 15 6 21
2018 Mayo 9 8 17
2018 Abril 18 2 20
2018 Marzo 16 4 20
2018 Febrero 20 5 25
2018 Enero 12 1 13
2017 Diciembre 17 6 23
2017 Noviembre 10 3 13
2017 Octubre 14 4 18
2017 Septiembre 10 2 12
2017 Agosto 18 10 28
2017 Julio 9 2 11
2017 Junio 14 5 19
2017 Mayo 7 0 7
2017 Abril 14 1 15
2017 Marzo 6 1 7
2017 Febrero 9 3 12
2017 Enero 2 0 2
2016 Diciembre 18 3 21
2016 Noviembre 19 5 24
2016 Octubre 36 3 39
2016 Septiembre 47 3 50
2016 Agosto 53 1 54
2016 Julio 79 0 79
2016 Junio 54 0 54
2016 Mayo 53 0 53
2016 Abril 44 0 44
2016 Marzo 27 0 27
2016 Febrero 26 0 26
2016 Enero 11 0 11
2015 Diciembre 31 0 31
2015 Noviembre 21 0 21
2015 Octubre 16 0 16
2015 Septiembre 29 0 29
2015 Agosto 27 0 27
2015 Julio 14 0 14
2015 Junio 6 0 6
2015 Mayo 14 0 14
Mostrar todo

Siga este enlace para acceder al texto completo del artículo

Idiomas
Nefrología
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?